Market Overview

UPDATE: Stifel Nicolaus Raises PT to $24 on Ixia On Above-Seasonal Guidance

Related XXIA
Mid-Afternoon Market Update: Infosys Rises Following Q4 Results; Ixia Shares Slide
Mid-Day Market Update: Super Micro Computer Drops Following Weak Guidance; Bio Blast Pharma Shares Surge

Stifel Nicolaus reiterated its Buy rating on Ixia (NASDAQ: XXIA) and raised its price target from $22.00 to $24.00.

Stifel Nicolaus commented, "1Q13 guidance bucks traditional seasonality with management targeting continued growth from acquisitions (up 6% q/q at the mid-point) and flattish sequential core revenue. BreakingPoint and Anue should also contribute to the GM% profile sequentially, netting to a pro forma EPS guidance range of $0.23-$0.25, above the consensus of $0.20 (even when normalizing for a $0.02/$0.03 federal R&D tax credit benefit). … Overall, we positively view results and guidance with management's tone clearly positive, noting several opportunities to expand newly acquired businesses internationally while also integrating functionality across Ixia's core product portfolio."

Ixia closed at $19.80 on Wednesday.

Latest Ratings for XXIA

Jul 2016Stifel NicolausUpgradesHoldBuy
Feb 2016WunderlichUpgradesHoldBuy
Feb 2016JefferiesMaintainsHold

View More Analyst Ratings for XXIA
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings


Related Articles (XXIA)

View Comments and Join the Discussion!